Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT02816697
Official study title

Implementation of a System-level Tobacco Treatment Intervention

Study summary

The proposed study plans to adapt and study the implementation and effectiveness of integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the thoracic oncology setting using mixed methods.

Ask AI to explain this study
Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedCEASE and Usual Care Tobacco Treatment Services

The study team can explain what participation involves.

Who it may be forSmoking Cessation · Lung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 16, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?Dana-Farber Cancer Institute

Study sponsor

01
Study overview

What this study is about

Purpose
Supportive Care
Study type
Interventional
Phase
Not applicable
Sponsor
Dana-Farber Cancer Institute
Interventions being studied
Other: CEASE; Other: Usual Care Tobacco Treatment Services
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Age ≥ 18
  • Have an actual or potential diagnosis of thoracic malignancy
  • Able to read and write in English.
  • Current or recent former smoker (defined as having smoked within past 6 months)
  • Must have an active telephone number.
Reasons someone may not be able to joinExclusion criteria
  • Former smoker greater than 6 months.
  • Have any of the below conditions needing immediate medical intervention
  • Hypercalcemia causing lethargy and confusion,
  • Acute respiratory distress
  • Dehydration
  • Hypotension

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Brigham and Women's HospitalBoston, Massachusetts
  • Dana Farber Cancer InstituteBoston, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 16, 2026. Always confirm current availability with the study team.

View original record ↗